Septrin in the treatment of dermatitis cruris pustulosa et atrophicans

Abstract

The results of treatment of 30 Nigerian patients suffering from dermatitis cruris pustulosa et atrophicans by a 7-week course of Septrin are described. Septrin was effective in twenty-three of twenty-four patients who completed the study. The best therapeutic effects were observed in the early, pustular phase of the disease.